Vaccination

Annual two-dose SARS-CoV-2 vaccination campaign beneficial

Annual administration of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine five months after the initial dose results in fewer hospitalizations and deaths, according to a study published ...

Immunology

FDA adds Fasenra indication for severe asthma in children

The U.S. Food and Drug Administration has approved an additional indication for AstraZeneca's Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years with severe asthma and an eosinophilic ...

page 3 from 7